Aetna prior authorization and CPT code lookup, page 13
CPT code lookup
Each row is one code from the participating-provider precertification list. This is not a coding dictionary, and it is not a coverage decision. The description is the service name on that list.
Participating-provider outpatient list
Inpatient, emergency, and observation settings are outside this outpatient list. This page does not publish a determination for those settings.
Prior authorization codes
| Code | Description | Source |
|---|---|---|
| J7204 | Esperoct antihemophilic factor [recombinant], glycopegylated-exei | Participating provider precertification list for Aetna, Pg 16 Original policy |
| J7191 | Factor XIII Factor viii (antihemophilic factor (porcine) | Participating provider precertification list for Aetna, Pg 16 Original policy |
| J7198 | FEIBA, FEIBA NF anti-inhibitor coagulant complex | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7176 | Fesilty fibrinogen, human-chmt — precertification required effective July 1, 2026 | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7177 | Fibryga fibrinogen, human | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J1411 | Hemgenix etranacogene dezaparvovec — precertification required for the drug and site of care | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7170 | Hemlibra emicizumab | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7190 | Hemofil M antihemophilic factor [human] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7199 | Hemophilia clotting factor not otherwise classified | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7187 | Humate-P antihemophilic factor/von Willebrand factor complex [human] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7202 | Idelvion antihemophilic factor [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7195 | Ixinity coagulation factor IX [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7213 | Ixinity coagulation factor IX [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7208 | Jivi antihemophilic factor [recombinant], PEGylated-aucl | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7192 | Kogenate FS antihemophilic factor [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7211 | Kovaltry antihemophilic factor [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7182 | NovoEight antihemophilic factor [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7189 | NovoSeven RT coagulation factor VIIa [recombinant] | Participating provider precertification list for Aetna, Pg 17 Original policy |
| J7209 | Nuwiq simoctocog alfa | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7188 | Obizur antihemophilic factor [recombinant], porcine sequence | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7194 | Profilnine factor IX complex | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7203 | Rebinyn coagulation factor IX [recombinant], glycoPEGylated | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7192 | Recombinate antihemophilic factor [recombinant] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7178 | RiaSTAP fibrinogen concentrate [human] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7200 | Rixubis coagulation factor IX [recombinant] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J1412 | Roctavian valoctocogene roxaparvovec-rvox — precertification required for the drug and site of care | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7212 | Sevenfact coagulation factor VIIa [recombinant]-jncw | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7181 | Tretten coagulation factor XIII a-subunit [recombinant] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7179 | Vonvendi von Willebrand factor [recombinant] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7183 | Wilate von Willebrand factor/coagulation factor VIII complex [human] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J7185 | Xyntha, Xyntha Solofuse antihemophilic factor [recombinant] | Participating provider precertification list for Aetna, Pg 18 Original policy |
| J9264 | Abraxane (paclitaxel protein-bound particles) — precertification required for Medicare Advantage members only | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0801 | Acthar Gel/H. P. Acthar (corticotropin) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0802 | Acthar Gel/H. P. Acthar (corticotropin) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0791 | Adakveo (crizanlizumab-tmca) — precertification required for the drug and site of care | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J9042 | Adcetris (brentuximab vedotin) — precertification required for drug and site of care | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J9029 | Adstiladrin (nadofaragene firadenovec-vncg) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0256 | Alpha 1-proteinase inhibitor (human) (precertification required for the drug and site of care): Aralast NP (alpha 1-proteinase inhibitor) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0257 | Alpha 1-proteinase inhibitor (human) (precertification required for the drug and site of care): Glassia (alpha 1-proteinase inhibitor) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0256 | Alpha 1-proteinase inhibitor (human) continued: Prolastin-C (alpha 1-proteinase inhibitor) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0256 | Alpha 1-proteinase inhibitor (human) continued: Zemaira (alpha 1-proteinase inhibitor) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| Q5126 | Alymsys (bevacizumab) — precertification required for the drug and site of care for oncology indications only | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0175 | Alzheimer’s disease (precertification required for the drug and site of care): Kisunla (donanemab-azbt) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J0174 | Alzheimer’s disease (precertification required for the drug and site of care): Leqembi IV (lecanemab-irmb) | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J3490 | Alzheimer’s disease (precertification required for the drug and site of care): Leqembi SQ (lecanemab-irmb) — precertification required for Medicare | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J3590 | Alzheimer’s disease (precertification required for the drug and site of care): Leqembi SQ (lecanemab-irmb) — precertification required for Medicare | Participating provider precertification list for Aetna, Pg 19 Original policy |
| C9399 | Alzheimer’s disease (precertification required for the drug and site of care): Leqembi SQ (lecanemab-irmb) — precertification required for Medicare | Participating provider precertification list for Aetna, Pg 19 Original policy |
| J3490 | Amtagvi (lifileucel,) — precertification required for the drug and site of care Contact National Medical Excellence | Participating provider precertification list for Aetna, Pg 20 Original policy |
| J3590 | Amtagvi (lifileucel,) — precertification required for the drug and site of care Contact National Medical Excellence | Participating provider precertification list for Aetna, Pg 20 Original policy |
| C9399 | Amtagvi (lifileucel,) — precertification required for the drug and site of care Contact National Medical Excellence | Participating provider precertification list for Aetna, Pg 20 Original policy |
Aetna precertification list
The participating-provider examples point at the official list. Open the list itself for the current file, including its effective date.
Plan and setting exceptions
Student Health and Allina Health / Aetna are separate from the participating-provider rows above.
Prior authorization forms
| Product or plan | Benefit | Route |
|---|---|---|
| Use the plan named on the official form page | Medical and pharmacy forms are listed by Aetna | Aetna health care professional forms |
This page does not reproduce a form and does not list a fax number that was not read from the form page.